Abstract
RNA interference, the process in which small interfering RNAs (SiRNAs) silence a specific gene and thus inhibit the associated protein, has opened new doors for the treatment of a wide range of diseases. However, efficient delivery of SiRNAs remains a challenge, especially due to their instability in biological environments and their inability to cross cell membranes. To protect and deliver SiRNAs to mammalian cells, a variety of polymeric nanocarriers have been developed. Among them, the polysaccharide chitosan has generated great interests. This derivative of natural chitin is biodegradable and biocompatible, and can complex SiRNAs into nanoparticles on account of its positive charges. However, chitosan presents some limitations that need to be taken into account when designing chitosan/SiRNA nanoparticles. Here, we describe a method to prepare SiRNA/chitosan nanoparticles with high gene silencing efficiency and low cytotoxicity by using the ionic gelation technique.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Mao S, Sun W, Kissel T (2010) Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev 62:12–27
Baldrick P (2010) The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmacol 56:290–299
Kean T, Thanou M (2010) Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev 62:3–11
Raemdonck K, Martens TF, Braeckmans K, Demeester J, De Smedt SC (2013) Polysaccharide-based nucleic acid nanoformulations. Adv Drug Deliv Rev 65:1123–1147
Liu X, Howard KA, Dong M, Andersen MO, Rahbek UL, Johnsen MG, Hansen OC, Besenbacher F, Kjems J (2007) The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials 28:1280–1288
Katas H, Alpar HO (2006) Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release 115:216–225
Ragelle H, Vandermeulen G, Preat V (2013) Chitosan-based siRNA delivery systems. J Control Release 172:207–218
Kim TH, Kim SI, Akaike T, Cho CS (2005) Synergistic effect of poly(ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes. J Control Release 105:354–366
Lai WF, Lin MC (2009) Nucleic acid delivery with chitosan and its derivatives. J Control Release 134:158–168
Ragelle H, Riva R, Vandermeulen G, Naeye B, Pourcelle V, Le Duff CS, D’Haese C, Nysten B, Braeckmans K, De Smedt SC, Jerome C, Preat V (2014) Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency. J Control Release 176:54–63
Jensen DM, Cun D, Maltesen MJ, Frokjaer S, Nielsen HM, Foged C (2010) Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation. J Control Release 142:138–145
Acknowledgement
This work was supported by the Walloon Region (BioWin project TARGETUM).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Ragelle, H., Vanvarenberg, K., Vandermeulen, G., Préat, V. (2016). Chitosan Nanoparticles for SiRNA Delivery In Vitro. In: Shum, K., Rossi, J. (eds) SiRNA Delivery Methods. Methods in Molecular Biology, vol 1364. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3112-5_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3112-5_12
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3111-8
Online ISBN: 978-1-4939-3112-5
eBook Packages: Springer Protocols